Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328
Q4 FY25 results · Jan–Mar 2025
Krsnaa Diagnostics reported revenue from operations of ₹186.08 crore (up 11.9% from Q4 FY24) and net profit of ₹20.68 crore (up 10.4% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 186.08 | 166.28 | +11.9% | 174.51 | +6.6% |
| Other income | 4.39 | 4.34 | +1.2% | 9.24 | −52.5% |
| Total income | 190.46 | 170.62 | +11.6% | 183.75 | +3.7% |
| Profit before tax | 28.61 | 22.61 | +26.5% | 25.48 | +12.3% |
| Net profit for the period | 20.68 | 18.73 | +10.4% | 19.41 | +6.5% |
| EPS, basic (₹) | 6.40 | 5.80 | +10.3% | 6.01 | +6.5% |
| Net margin (%) | 11.1 | 11.3 | 11.1 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 174.65 | 159.33 | +9.6% | 165.16 | +5.7% |
| Other income | 4.46 | 4.34 | +2.7% | 9.29 | −52.0% |
| Total income | 179.11 | 163.67 | +9.4% | 174.45 | +2.7% |
| Profit before tax | 29.21 | 22.18 | +31.7% | 28.37 | +3.0% |
| Net profit for the period | 21.07 | 18.42 | +14.4% | 21.60 | −2.5% |
| EPS, basic (₹) | 6.52 | 5.70 | +14.4% | 6.69 | −2.5% |
| Net margin (%) | 12.1 | 11.6 | 13.1 |
Consolidated
- Filed with BSE
- 12 May 2025, 20:12 IST
- Board meeting
- 12 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 May 2025, 20:12 IST
- Board meeting
- 12 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE